Barclays PLC Surface Oncology, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
SELL
$0.61 - $1.03 $47,620 - $80,407
-78,066 Reduced 72.74%
29,251 $20,000
Q4 2022

Feb 13, 2023
SELL
$0.62 - $1.21 $192,477 - $375,642
-310,448 Reduced 74.31%
107,317 $88,000
Q3 2022

Nov 03, 2022
SELL
$1.05 - $2.1 $13,695 - $27,390
-13,043 Reduced 3.03%
417,765 $434,000
Q2 2022

Aug 12, 2022
BUY
$1.42 - $3.15 $462,478 - $1.03 Million
325,689 Added 309.83%
430,808 $707,000
Q1 2022

May 16, 2022
BUY
$2.65 - $5.08 $115,232 - $220,898
43,484 Added 70.55%
105,119 $310,000
Q4 2021

Feb 14, 2022
BUY
$4.73 - $7.9 $174,049 - $290,696
36,797 Added 148.15%
61,635 $295,000
Q3 2021

Nov 09, 2021
SELL
$5.16 - $7.98 $178,886 - $276,650
-34,668 Reduced 58.26%
24,838 $189,000
Q2 2021

Aug 13, 2021
SELL
$6.45 - $9.09 $213,765 - $301,260
-33,142 Reduced 35.77%
59,506 $444,000
Q1 2021

May 13, 2021
BUY
$7.25 - $13.82 $671,074 - $1.28 Million
92,562 Added 107630.23%
92,648 $723,000
Q4 2020

Feb 11, 2021
BUY
$6.87 - $10.48 $590 - $901
86 New
86 $1,000
Q3 2020

Nov 12, 2020
SELL
$5.06 - $7.23 $52,563 - $75,105
-10,388 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$1.57 - $6.56 $16,309 - $68,145
10,388 New
10,388 $68,000
Q1 2020

May 13, 2020
SELL
$1.44 - $3.95 $29,256 - $80,252
-20,317 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$1.17 - $2.33 $917 - $1,826
-784 Reduced 3.72%
20,317 $38,000
Q3 2019

Nov 14, 2019
SELL
$1.4 - $2.84 $6,095 - $12,365
-4,354 Reduced 17.1%
21,101 $30,000
Q2 2019

Aug 14, 2019
BUY
$2.75 - $4.89 $60,390 - $107,384
21,960 Added 628.33%
25,455 $71,000
Q1 2019

May 15, 2019
BUY
$4.11 - $5.88 $14,364 - $20,550
3,495 New
3,495 $16,000
Q4 2018

Feb 14, 2019
SELL
$3.65 - $10.69 $9,942 - $29,119
-2,724 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$8.92 - $17.83 $19,552 - $39,083
2,192 Added 412.03%
2,724 $30,000
Q2 2018

Aug 14, 2018
BUY
$12.83 - $17.41 $6,825 - $9,262
532 New
532 $9,000

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email